Acute Anterior Choroidal Artery Territory Infarction: A Retrospective Study

Zhe Cheng1, Honglian Duan1, Fanhua Meng1

  • 1Department of Neurology, Beijing Luhe Hospital, Capital Medical University, Beijing 101149, China.

Insights

Clinical progression in anterior choroidal artery (AChA) strokes is linked to multiple risk factors and large vessel disease. Intravenous thrombolysis therapy (IVT) did not significantly alter progression or prognosis in these patients.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Stroke Medicine

Background:

  • Acute ischemic stroke (AIS) in the anterior choroidal artery (AChA) territory presents unique clinical challenges.
  • Understanding risk factors and progression patterns is crucial for effective patient management.

Purpose of the Study:

  • To investigate the clinical features, risk factors, and progression of AIS in the AChA territory.
  • To evaluate the impact of intravenous thrombolysis therapy (IVT) on clinical progression and prognosis.
  • To identify factors influencing the prognosis of AChA infarction.

Main Methods:

  • Retrospective analysis of 113 patients with AChA infarction.
  • Collection and comparison of demographic and clinical characteristics.
  • Analysis of clinical progression, outcome, and IVT use.

Main Results:

  • Hemiparesis was the most common symptom (92.9%).
  • Clinical progression was associated with multiple risk factors, carotid plaques, and stenosis.
  • Good prognosis at 6 months was observed in 69.9% of patients; factors like atrial fibrillation and large infarct size were linked to poor outcomes.
  • No significant difference in clinical progression or prognosis was found between patients who received IVT and those who did not.

Conclusions:

  • Motor deficits are typical in AChA infarcts.
  • Large vascular disease, not just small artery disease, may contribute to clinical progression.
  • Prognosis is influenced by clinical progression, infarct size, and atrial fibrillation.
  • IVT did not appear to prevent clinical progression or improve prognosis in this cohort.
Abstract